Access the full text.
Sign up today, get DeepDyve free for 14 days.
John Taranger, Birger Trollfors, N. Knutsson, Valter Sundh, T. Lagergård, Erik Østergaard (1999)
Vaccination of infants with a four-dose and a three-dose vaccination schedule.Vaccine, 18 9-10
B. Trollfors, J. Taranger, T. Lagergård, L. Lind, V. Sundh, G. Zackrisson, Charles Lowe, W. Blackwelder, J. Robbins (1995)
A placebo-controlled trial of a pertussis-toxoid vaccine.The New England journal of medicine, 333 16
W. Hattie
DIPHTHERIA TOXOID.Canadian Medical Association journal, 17 3
M. Tiru, H. Hallander, L. Gustafsson, J. Storsaeter, P. Olin (2000)
Diphtheria antitoxin response to DTP vaccines used in Swedish pertussis vaccine trials, persistence and projection for timing of booster.Vaccine, 18 21
E. Bergfors, B. Trollfors, A. Inerot (2003)
Unexpectedly high incidence of persistent itching nodules and delayed hypersensitivity to aluminium in children after the use of adsorbed vaccines from a single manufacturer.Vaccine, 22 1
P. Beverley (2002)
Immunology of vaccination.British medical bulletin, 62
R. Carlsson, B. Claesson, Eva Fagerlund, N. Knutsson, C. Lundin (2002)
Antibody persistence in five-year-old children who received a pentavalent combination vaccine in infancyThe Pediatric Infectious Disease Journal, 21
Vaccines , Immunization and Biologicals . Statistics and Graphics
B. Trollfors, J. Taranger, T. Lagergård, V. Sundh (2005)
REDUCED IMMUNOGENICITY OF DIPHTHERIA AND TETANUS TOXOIDS WHEN COMBINED WITH PERTUSSIS TOXOIDThe Pediatric Infectious Disease Journal, 24
K. Edwards, B. Meade, M. Decker, G. Reed, M. Rennels, M. Steinhoff, E. Anderson, J. Englund, M. Pichichero, M. Deloria, A. Deforest (1995)
Comparison of 13 acellular pertussis vaccines: overview and serologic response.Pediatrics, 96 3 Pt 2
E. Danilova, A. Shiryayev, V. Skogen, E. Kristoffersen, H. Sjursen (2005)
Short-term booster effect of diphtheria toxoid in initially long-term protected individuals.Vaccine, 23 12
B. Claesson, B. Trollfors, T. Lagergård, J. Taranger, D. Bryla, Gabriel Otterman, T. Cramton, Yonghong Yang, C. Reimer, J. Robbins, R. Schneerson (1988)
Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old children.The Journal of pediatrics, 112 5
S. Lugauer, U. Heininger, J. Cherry, K. Stehr (2002)
Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell pertussis component vaccineEuropean Journal of Pediatrics, 161
T. Lagergård, B. Trollfors, B. Claesson, J. Karlberg, J. Taranger (1992)
Determination of neutralizing antibodies and specific immunoglobulin isotype levels in infants after vaccination against diphtheriaEuropean Journal of Clinical Microbiology and Infectious Diseases, 11
P. Olin, L. Gustafsson, L. Barreto, L. Hessel, T. Mast, A. Rie, H. Bogaerts, J. Storsaeter (2003)
Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine.Vaccine, 21 17-18
C. Vitek, M. Brennan, C. Gotway, V. Bragina, Nadezhda Govorukina, O. Kravtsova, P. Rhodes, K. Bisgard, P. Strebel (1999)
Risk of diphtheria among schoolchildren in the Russian Federation in relation to time since last vaccinationThe Lancet, 353
(1995)
Clinical trials of a monocomponent pertussis toxoid vaccine – a technical report
(1998)
toxoid. In: Plotkin SA, Orenstein WA (eds) Vaccines
D. Granoff, A. Lucas (1995)
Laboratory Correlates of Protection against Haemophilus influenzae Type b DiseaseAnnals of the New York Academy of Sciences, 754
L. Nilsson, G. Faldella, J. Jacquet, J. Storsaeter, S. Silfverdal, L. Ekholm (2005)
A fourth dose of DTPa-IPV vaccine given to 4–6 year old children in Italy and Sweden following primary vaccination at 3, 5 and 11–12 months of ageScandinavian Journal of Infectious Diseases, 37
In an open study, 502 10-year-old children, who had received primary vaccination against diphtheria and tetanus in infancy and had varying histories of pertussis disease and vaccination, were vaccinated with diphtheria-tetanus vaccine (DT) alone or with the addition of 20 µg or 40 μg of pertussis toxoid. Diphtheria toxin neutralising antibodies, pertussis toxin IgG and tetanus toxoid IgG antibodies were measured before and 1 month after the booster. All toxoids were highly immunogenic. In pertussis toxoid recipients, median levels of pertussis toxin IgG increased to 16.5 U/ml (DTaP20) and to 36 U/ml (DTaP40) in children with non-detectable (<1 U/ml) antibodies before vaccination and to >400 U/ml in children (both DTaP20 and DTaP40) with detectable antibodies before vaccination. A total of 60 children (12%) with non-detectable (<0.01 IU/ml) diphtheria antibodies and 36 children (7%) with non-detectable (<0.01 IU/ml) tetanus antibodies before the booster had lower median antibody concentrations post-vaccination than children with detectable antibodies before the booster (diphtheria: 5.12 vs. 20.48 IU/ml; tetanus: 4.0 vs. 10.0 IU/ml). There were no differences in diphtheria and tetanus antibodies after vaccination between children who did and did not receive pertussis toxoid. Conclusion:10-year-old children with non-detectable diphtheria and tetanus antibodies before the booster had lower post-vaccination antibodies than those with detectable antibodies before the booster indicating a poor immunological memory. Addition of pertussis toxoid to diphtheria-tetanus vaccine did not affect the antibody responses to diphtheria and tetanus toxoids when the three toxoids were combined as a booster. Even though immunity to diphtheria and tetanus was only estimated by surrogate markers (serum antitoxin antibodies) the results indicate that a lower age for the booster dose of diphtheria-tetanus vaccine or diphtheria-tetanus acellular pertussis vaccine should be considered.
European Journal of Pediatrics – Springer Journals
Published: Oct 26, 2005
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.